MARKET

NTUS

NTUS

Natus Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.48
+0.50
+1.83%
Opening 10:43 04/21 EDT
OPEN
26.87
PREV CLOSE
26.98
HIGH
27.53
LOW
26.20
VOLUME
18.27K
TURNOVER
--
52 WEEK HIGH
28.83
52 WEEK LOW
16.38
MARKET CAP
930.69M
P/E (TTM)
-56.0943
1D
5D
1M
3M
1Y
5Y
Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences
Zacks.com · 2d ago
5 MedTech Outperformers With Nearly 40% or More Gain in 2021
Zacks.com · 5d ago
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15)
Benzinga · 5d ago
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14)
Benzinga · 6d ago
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13)
Benzinga · 04/14 11:51
Natus to Participate in the 20th Annual Needham Virtual Healthcare Conference
Natus Medical Incorporated (NASDAQ: NTUS) (the "Company" or "Natus"), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonat...
GlobeNewswire · 04/08 20:15
Natus Medical to Hold 2021 First Quarter Financial Results Conference Call on May 6th
PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disord...
GlobeNewswire · 04/01 21:10
Zacks.com featured highlights include: Rocky Brands, Stamps.com, Owens & Minor, Natus Medical and Toyota Motor
Zacks.com · 04/01 11:37
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NTUS. Analyze the recent business situations of Natus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NTUS stock price target is 36.00 with a high estimate of 36.00 and a low estimate of 36.00.
EPS
Institutional Holdings
Institutions: 260
Institutional Holdings: 34.42M
% Owned: 101.62%
Shares Outstanding: 33.87M
TypeInstitutionsShares
Increased
50
1.89M
New
22
686.53K
Decreased
61
2.41M
Sold Out
17
236.63K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.60%
Healthcare Equipment & Supplies
+1.57%
Key Executives
Chairman/Independent Director
Barbara Paul
President/Chief Executive Officer/Director
Jonathan Kennedy
Chief Financial Officer/Executive Vice President/IR Contact Officer
Drew Davies
Chief Financial Officer/Executive Vice President/IR Contact Officer
B. Drew Davies
Chief Human Resource Officer/Vice President
Lisa Paul
Executive Vice President
Austin Noll
Vice President - Operations
Sean Langan
Vice President
D. Christopher Chung
General Counsel
William Hill
Independent Director
Ilan Daskal
Independent Director
Lisa Heine
Independent Director
Joshua Levine
Independent Director
Kenneth Ludlum
Independent Director
Alice Schroeder
Independent Director
Thomas Sullivan
No Data
About NTUS
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Webull offers kinds of Natus Medical Inc stock information, including NASDAQ:NTUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTUS stock methods without spending real money on the virtual paper trading platform.